KRAS and neoplasm: Spindler et al [20] used ARMS method to detect KRAS mutation in matched tumor tissue and plasma samples from 211 mCRC patients, and the overall concordance rate was 85.0%, with sensitivity of 80.0% and specificity of 95.8%.